COVID-19 in patients with acute lymphoblastic leukemia

COVID-19 in patients with acute lymphoblastic leukemia

Background. Patients with acute lymphoblastic leukemia (ALL) have been the most vulnerable group of patients at risk of severe and extremely severe COVID-19 throughout the coronavirus pandemic. Secondary immunodeficiency due to acute leukemia, as well as antitumor treatment, predisposes to the devel...

Full description

Saved in:
Bibliographic Details
Main Authors: T.   S. Chudnova, E. N. Misyurina, E. A. Baryakh, T. N. Tolstykh, L. T. Shimanovskaya, D. E. Gagloeva, E. I. Zhelnova, A. B. Makeshova, K. V. Yatskov, E. N. Zotina, D. D. Ivanova, M. A. Mingalimov, O. L. Kochneva, E. Yu. Grishina, V. N. Yakimets
Format: Article
Language:Russian
Published: ABV-press 2024-09-01
Series:Онкогематология
Subjects:
adult acute lymphoblastic leukemia
coronavirus disease
chemotherapy
Online Access:https://oncohematology.abvpress.ru/ongm/article/view/953
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://oncohematology.abvpress.ru/ongm/article/view/953

Similar Items